Semaglutide could protect against Alzheimer’s disease
medicine Tuesday, October 29, 2024 Cleveland/Ohio Although the GLP-1 agonist semaglutide has only been used for a few years, an analysis of electronic medical records in Alzheimers & Dementia (2024; DOI: 10.1002/alz.14313) indicates a decline